Andreeva Anna Y, Piontek Jörg, Blasig Ingolf E, Utepbergenov Darkhan I
Forschungsinstitut für Molekulare Pharmakologie, Robert-Rössle-Str. 10, 13125 Berlin-Buch, Germany.
Int J Biochem Cell Biol. 2006 Feb;38(2):222-33. doi: 10.1016/j.biocel.2005.09.001. Epub 2005 Sep 27.
Apparently conflicting observations indicated that protein kinase C both may block and support the assembly of tight junctions. We therefore tested the hypothesis that different isoenzymes antagonistically affect tight junction proteins and function. Thus, by using specific inhibitors we investigated the involvement of conventional and novel protein kinase C of kidney tubule cells in tight junction assembly. In low Ca2+ medium, the application of pan-protein kinase C inhibitor GF-109203X blocked the formation of tight junctions induced by protein kinase C agonist diacyglycerol. Gö6976, inhibitor of conventional protein kinase C, promoted the formation of tight junctions and occludin phosphorylation in cells cultivated in low Ca2+ medium and attenuated the disruption of tight junction complex induced by the switch to low Ca2+ medium. In addition, Gö6976 accelerated the occludin phosphorylation and the formation of tight junction barrier during assembly of tight junctions induced by Ca2+ re-addition. This phosphorylation was accompanied by accelerated occludin incorporation into newly forming tight junctions and by reducing the paracellular permeability. In contrast, inhibitor of novel protein kinase C rottlerin blocked the occludin phosphorylation and the formation of tight junction barrier, both caused by re-addition of normal Ca2+ medium. It is concluded that the conventional protein kinase C alpha participates in tight junction disassembly while the novel protein kinase C epsilon plays a role in tight junction formation of kidney epithelial cells. The discovered antagonism contributes to a better understanding of the regulation of the structure and function of tight junctions and hence to that of the epithelial barrier.
明显相互矛盾的观察结果表明,蛋白激酶C既可能阻碍又可能支持紧密连接的组装。因此,我们检验了这样一个假设,即不同的同工酶对紧密连接蛋白和功能具有拮抗作用。于是,我们使用特异性抑制剂研究了肾小管细胞中传统型和新型蛋白激酶C在紧密连接组装中的作用。在低钙培养基中,泛蛋白激酶C抑制剂GF-109203X的应用阻断了蛋白激酶C激动剂二酰甘油诱导的紧密连接形成。传统蛋白激酶C的抑制剂Gö6976促进了在低钙培养基中培养的细胞中紧密连接的形成和闭合蛋白的磷酸化,并减弱了因切换到低钙培养基而导致的紧密连接复合体的破坏。此外,在重新添加钙离子诱导紧密连接组装过程中,Gö6976加速了闭合蛋白的磷酸化和紧密连接屏障的形成。这种磷酸化伴随着闭合蛋白更快地掺入新形成的紧密连接中,并降低了细胞旁通透性。相反,新型蛋白激酶C的抑制剂rottlerin阻断了正常钙培养基重新添加所导致的闭合蛋白磷酸化和紧密连接屏障的形成。结论是,传统蛋白激酶Cα参与紧密连接的解体,而新型蛋白激酶Cε在肾上皮细胞紧密连接的形成中发挥作用。所发现的拮抗作用有助于更好地理解紧密连接结构和功能的调节,从而有助于理解上皮屏障的调节。